tiprankstipranks
Roche Holding AG (DE:RHOA)
FRANKFURT:RHOA
Germany Market
RHOA
Roche Holding AG
RESEARCH TOOLSreports

Roche Holding AG (RHOA) Stock Forecast & Price Target

72 Followers
See the Price Targets and Ratings of:

RHOA Analyst Ratings

Hold
6Ratings
Hold
2 Buy
3 Hold
1 Sell
Based on 6 analysts giving stock ratings to
Roche
Holding AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RHOA Stock 12 Month Forecast

Average Price Target

€379.57
▼(-2.29% Downside)
Based on 6 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is €379.57 with a high forecast of €465.11 and a low forecast of €246.20. The average price target represents a -2.29% change from the last price of €388.45.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"245":"€245","466":"€466","300.25":"€300.3","355.5":"€355.5","410.75":"€410.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":465.113132,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€465.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":379.56585666666666,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€379.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":246.20488,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€246.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[245,300.25,355.5,410.75,466],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,377.15,383.91639476923075,390.6827895384615,397.4491843076923,404.21557907692306,410.98197384615383,417.7483686153846,424.5147633846154,431.28115815384615,438.0475529230769,444.8139476923077,451.58034246153846,458.34673723076924,{"y":465.113132,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,377.15,377.33583512820513,377.52167025641023,377.7075053846154,377.8933405128205,378.07917564102564,378.26501076923074,378.4508458974359,378.636681025641,378.82251615384615,379.00835128205125,379.1941864102564,379.3800215384615,{"y":379.56585666666666,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,377.15,367.0772984615384,357.0045969230769,346.93189538461536,336.85919384615386,326.7864923076923,316.71379076923074,306.64108923076924,296.5683876923077,286.4956861538461,276.4229846153846,266.35028307692306,256.2775815384615,{"y":246.20488,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":261.982,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":268.24,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":291.091,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":271.199,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 20</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":323.547,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":342.856,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":373.809,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":391.274,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348.25,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":346.65,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":357.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":377.15,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€465.11Average Price Target€379.57Lowest Price Target€246.20
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on DE:RHOA
Justin Smith
Bernstein
Bernstein
€422.83→€465.11
Buy
19.74%
Upside
Reiterated
07/27/26
Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Atricure (NASDAQ: ATRC)
Deutsche Bank Analyst forecast on DE:RHOA
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
€363.96
Hold
-6.31%
Downside
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (NASDAQ: ZVRA), Roche Holding AG (Other OTC: RHHVF) and Quest Diagnostics (NYSE: DGX)
HSBC Analyst forecast on DE:RHOA
Rajesh Kumar
HSBC
HSBC
€390.72
Hold
0.58%
Upside
Downgraded
07/06/26
Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC
Goldman Sachs Analyst forecast on DE:RHOA
James Quigley
Goldman Sachs
Goldman Sachs
€370.38→€372.52
Hold
-4.10%
Downside
Reiterated
06/30/26
Analysts Offer Insights on Healthcare Companies: Replimune Group (NASDAQ: REPL) and Roche Holding AG (Other OTC: RHHVF)
Jefferies Analyst forecast on DE:RHOA
Michael Leuchten
Jefferies
Jefferies
€246.2
Sell
-36.62%
Downside
Reiterated
06/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Inventiva (NASDAQ: IVA) and Roche Holding AG (Other OTC: RHHVF)
Barclays Analyst forecast on DE:RHOA
James Gordon CFA
Barclays
Barclays
€438.89
Buy
12.98%
Upside
Reiterated
05/26/26
Analysts Are Bullish on These Healthcare Stocks: Roche Holding AG (RHHVF), Cingulate Inc (CING)
UBS Analyst forecast on DE:RHOA
Matthew Weston
UBS
UBS
€411.06→€402.49
Buy
3.61%
Upside
Reiterated
05/13/26
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Berenberg Bank Analyst forecast on DE:RHOA
Luisa Hector
Berenberg Bank
Berenberg Bank
€363.96
Hold
-6.31%
Downside
Reiterated
05/08/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: CSL (Other OTC: CMXHF), Roche Holding AG (Other OTC: RHHVF) and Pfizer (NYSE: PFE)
Erste Group Analyst forecast on DE:RHOA
Hans Engel
Erste Group
Erste Group
―
Hold
―
Reiterated
05/04/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
J.P. Morgan Analyst forecast on DE:RHOA
Richard Vosser
J.P. Morgan
J.P. Morgan
€347.9
Hold
-10.44%
Downside
Reiterated
05/01/26
J.P. Morgan Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
Morgan Stanley Analyst forecast on DE:RHOA
Sarita Kapila
Morgan Stanley
Morgan Stanley
€315.78
Hold
-18.71%
Downside
Upgraded
04/24/26
Roche upgraded to Equal Weight from Underweight at Morgan StanleyRoche upgraded to Equal Weight from Underweight at Morgan Stanley
Kepler Capital Analyst forecast on DE:RHOA
David Evans
Kepler Capital
Kepler Capital
€444.24
Buy
14.36%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)
Citi Analyst forecast on DE:RHOA
Graham Parry
Citi
Citi
―
Buy
―
Reiterated
03/10/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
DZ BANK AG Analyst forecast on DE:RHOA
Elmar Kraus
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
02/02/26
Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on DE:RHOA
Justin Smith
Bernstein
Bernstein
€422.83→€465.11
Buy
19.74%
Upside
Reiterated
07/27/26
Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Atricure (NASDAQ: ATRC)
Deutsche Bank Analyst forecast on DE:RHOA
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
€363.96
Hold
-6.31%
Downside
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (NASDAQ: ZVRA), Roche Holding AG (Other OTC: RHHVF) and Quest Diagnostics (NYSE: DGX)
HSBC Analyst forecast on DE:RHOA
Rajesh Kumar
HSBC
HSBC
€390.72
Hold
0.58%
Upside
Downgraded
07/06/26
Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC
Goldman Sachs Analyst forecast on DE:RHOA
James Quigley
Goldman Sachs
Goldman Sachs
€370.38→€372.52
Hold
-4.10%
Downside
Reiterated
06/30/26
Analysts Offer Insights on Healthcare Companies: Replimune Group (NASDAQ: REPL) and Roche Holding AG (Other OTC: RHHVF)
Jefferies Analyst forecast on DE:RHOA
Michael Leuchten
Jefferies
Jefferies
€246.2
Sell
-36.62%
Downside
Reiterated
06/08/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Inventiva (NASDAQ: IVA) and Roche Holding AG (Other OTC: RHHVF)
Barclays Analyst forecast on DE:RHOA
James Gordon CFA
Barclays
Barclays
€438.89
Buy
12.98%
Upside
Reiterated
05/26/26
Analysts Are Bullish on These Healthcare Stocks: Roche Holding AG (RHHVF), Cingulate Inc (CING)
UBS Analyst forecast on DE:RHOA
Matthew Weston
UBS
UBS
€411.06→€402.49
Buy
3.61%
Upside
Reiterated
05/13/26
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Berenberg Bank Analyst forecast on DE:RHOA
Luisa Hector
Berenberg Bank
Berenberg Bank
€363.96
Hold
-6.31%
Downside
Reiterated
05/08/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: CSL (Other OTC: CMXHF), Roche Holding AG (Other OTC: RHHVF) and Pfizer (NYSE: PFE)
Erste Group Analyst forecast on DE:RHOA
Hans Engel
Erste Group
Erste Group
―
Hold
―
Reiterated
05/04/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
J.P. Morgan Analyst forecast on DE:RHOA
Richard Vosser
J.P. Morgan
J.P. Morgan
€347.9
Hold
-10.44%
Downside
Reiterated
05/01/26
J.P. Morgan Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
Morgan Stanley Analyst forecast on DE:RHOA
Sarita Kapila
Morgan Stanley
Morgan Stanley
€315.78
Hold
-18.71%
Downside
Upgraded
04/24/26
Roche upgraded to Equal Weight from Underweight at Morgan StanleyRoche upgraded to Equal Weight from Underweight at Morgan Stanley
Kepler Capital Analyst forecast on DE:RHOA
David Evans
Kepler Capital
Kepler Capital
€444.24
Buy
14.36%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)
Citi Analyst forecast on DE:RHOA
Graham Parry
Citi
Citi
―
Buy
―
Reiterated
03/10/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
DZ BANK AG Analyst forecast on DE:RHOA
Elmar Kraus
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
02/02/26
Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
GHRSGH Research
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

3 Months
David EvansKepler Capital
Success Rate
15/19 ratings generated profit
79%
Average Return
+8.24%
Copying David Evans's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.24% per trade.
1 Year
Matthew WestonUBS
Success Rate
14/14 ratings generated profit
100%
Average Return
+30.24%
Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.24% per trade.
2 Years
Elmar KrausDZ BANK AG
Success Rate
9/9 ratings generated profit
100%
Average Return
+50.13%
Copying Elmar Kraus's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +50.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RHOA Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
21
19
8
4
2
Hold
13
13
7
7
3
Sell
6
4
4
3
2
Strong Sell
0
0
0
0
0
total
40
36
19
14
7
In the current month, RHOA has received 2 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. RHOA average Analyst price target in the past 3 months is 379.57.
Each month's total comprises the sum of three months' worth of ratings.

RHOA Financial Forecast

RHOA Earnings Forecast

Next quarter’s earnings estimate for RHOA is €10.33 with a range of €10.08 to €10.66. The previous quarter’s EPS was €11.61. RHOA beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RHOA has Outperformed its overall industry.
Next quarter’s earnings estimate for RHOA is €10.33 with a range of €10.08 to €10.66. The previous quarter’s EPS was €11.61. RHOA beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RHOA has Outperformed its overall industry.

RHOA Sales Forecast

Next quarter’s sales forecast for RHOA is €34.58B with a range of €33.68B to €35.85B. The previous quarter’s sales results were €32.49B. RHOA beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RHOA has Outperformed its overall industry.
Next quarter’s sales forecast for RHOA is €34.58B with a range of €33.68B to €35.85B. The previous quarter’s sales results were €32.49B. RHOA beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RHOA has Outperformed its overall industry.

RHOA Stock Forecast FAQ

What is DE:RHOA’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding AG’s 12-month average price target is 379.57.
    What is DE:RHOA’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:RHOA, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Roche Holding AG a Buy, Sell or Hold?
        Roche Holding AG has a consensus rating of Hold, which is based on 2 buy ratings, 3 hold ratings and 1 sell ratings.
          What is Roche Holding AG’s share price target?
          The average share price target for Roche Holding AG is 379.57. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €465.11 ,and the lowest forecast is €246.20. The average share price target represents -2.29% Decrease from the current price of €388.45.
            What do analysts say about Roche Holding AG?
            Roche Holding AG’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Roche Holding AG?
              To buy shares of DE:RHOA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.